Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies

HIGHLIGHTS

• who: Hervé Lang from the of Brescia, Italy have published the research: Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies, in the Journal: (JOURNAL)
• what: The authors report here, like others , that PDXs derived from bladder and ureteral cancers preserved the histological and genomic properties of patient tumors.
• how: PCR products were separated by capillary electrophoresis on ABI PRISM 3100 and results were analyzed using the GeneMapper software. In line with these findings the authors identified a low EGFR regulon activity in a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.